CVM GFI #256 Compounding Animal Drugs from Bulk Drug Substances

Two Veterinarian Members of Congress Ask FDA to Extend Comment Period for GFI #256

0 comment(s)

On February 4, 2020, Kurt Schrader, DVM and Ted. S. Yoho, DVM sent this letter to the FDA:

 
February 4, 2020
 
Commissioner Stephen M. Hahn, M.D.
Food & Drug Administration
10903 New Hampshire Ave.
Silver Spring, MD 20993
 
Dear Commissioner Hahn,
 
We write today regarding FDA's draft Guidance for Industry (GFI) #256, "Compounding Animal Drugs 
from Bulk Drug Substances" ("OFT #256"), which was published in the Federal Register on November 

Three Pharmacy Associations Ask FDA to Extend Comment Period for GFI #256

0 comment(s)

On February 3, 2020, the American Pharmacists Association, the Alliance for Pharmacy Compounding, and the National Community Pharmacists Association sent this letter to the FDA:

Dockets Management Food and Drug Administration 
5630 Fishers Lane, Rm 1061 
Rockville, MD 20852
 
RE: FDA-2018-D-4533
 
To Whom It May Concern:
 

Pages